ORENTI, ANNALISA
ORENTI, ANNALISA
Dipartimento di Scienze Cliniche e di Comunità
Cystic fibrosis in Europe: improved lung function & longevity: reasons for cautious optimism, but challenges remain
2024 E. Kerem, A. Orenti, A. Adamoli, E. Hatziagorou, L. Naehrlich, I. Sermet-Gaudelus
Variability in Disease Severity Among Cystic Fibrosis Patients carrying Residual Function Variants: Data from the European Cystic Fibrosis Society Patient Registry
2024 M. Mei-Zahav, A. Orenti, A. Jung, E. Kerem
Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based study
2024 C. Kim, M. Higgins, L. Liu, N. Volkova, A. Zolin, L. Naehrlich, A. Pfleger, E. Lammertijn, D. Tješić-Drinković, P. Dřevínek, M.J. Macek, H. Vebert Olesen, N. Senecal, P.-. Burgel, G. Fletcher, R. Padoan, A. Orenti, F. Ambrogi, S. Gambazza, E. Aleksejeva, A.-. Charatsi, D. Zomer, E. Bakkeheim, L. Woźniacki, U. Krivec, C. Krantz, A. Lindblad, A. Jung, S. Clarke, S.B. Carr
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
2024 J. Semenchuk, Y. Naito, S.C. Charman, S.B. Carr, S.Y. Cheng, B.C. Marshall, A. Faro, A. Elbert, H.H. Gutierrez, C.H. Goss, B. Karadag, P. Burgel, C. Colombo, M. Salvatore, R. Padoan, G. Daneau, S. Harutyunyan, N. Kashirskaya, L. Kirwan, P.G. Middleton, R. Ruseckaite, I. de Monestrol, L. Naehrlich, P. Mondejar-Lopez, A. Jung, J. van Rens, E. Bakkeheim, A. Orenti, D. Zomer-van Ommen, L.V.R. da Silva-Filho, F.F. Fernandes, M. Zampoli, A.L. Stephenson, I. Kasmi, O. Drali, S. Burghart, A. Lakatos-Krepcik, J. Eder, P. Jaksch, K. Kainz, M. Kallinger, A. Leitner, M. Mozdzen, A. Pfleger, S. Renner, M. Stadlinger, C. Thir, E. Nuriyev, H. Boboli, E. De Wachter, L. Dupont, S. Gohy, L. Hanssens, C. Knoop, E. Lammertyn, V. Nowé, J. Pirson, M. Thimmesch, E. Van Braeckel, K. Van Hoorenbeeck, E. Vanderhelst, E.P. Filho, R.A. Athanazio, V.D.C. Martins, M.C. Duarte, L.D.F.V. Monte, M.B. de Fuccio, A.D.S.C. Knabben, R. Melloti, D.G. Meneses, G. Petrova, D. Tješić-Drinković, A.V. Dugac, I. Bambir, P. Yiallouros, A. Bilkova, P. Drevinek, M. Macek, H.V. Olesen, T. Pressler, E.M. Fouda, S. Nasr, A.Y. Weldetsadik, M. Al-iede, O. Abdrakhmanov, H. Corvol, L. Lemonnier-Videau, M. Abely, C.B. Piccini, C. Belleguic, T. Bihouee, Y. Billon, S. Bui, B. Camara, M. Cheraud, R. Chiron, E.C. Duet, L. Cosson, M. Dalphin, I.D. Boucher, S. De Miranda, E. Deneuville, J. Dubus, I. Durieu, R. Epaud, M. Gerardin, D. Grenet, V. Houdouin, F. Huet, K. Reem, R. Kessler, J. Languepin, M. Laurans, S. Leroy, C. Llerena, J. Macey, J. Mankikian, C. Marguet, C. Martin, L. Mely, M. Mittaine, M. Murris-Espin, C. Perisson, A. Prevotat, S. Ramel, C. Rames, P. Reix, M. Revillon, M. Reynaud-Gaubert, B. Richaud-Thiriez, J. Rittie, M. Scalbert-Dujardin, I. Sermet-Gaudelus, V. Storni, A. Tatopoulos, G. Thouvenin, F. Troussier, L. Weiss, N. Wizla, E. Behl, F. Brinkmann, M. Claßen, U. Graepler-Mainka, M. Griese, A. Grübl, J. Hammermann, H. Hebestreit, A. Heinzmann, A. Herz, A. Kiefer, B. Kinder, H. Köster, S. Kuhnert, J. Mainz, A. Mayer, S. Naehrig, T. Niehues, T. Nüßlein, K. Poplawska, F. Ringshausen, M. Rose, J. Rosenecker, R. Ruppel, A. Scharschinger, C. Schropp, C. Schwarz, C. Smaczny, O. Sommerburg, S. Sutharsan, S. Stolz, W. Thomas, S. Wege, B. Welzenbach, B. Wollschläger, F. Diamantea, E. Hatziagorou, K. Manika, D. Cox, B. Elnazir, G. Fletcher, C. Gunaratnam, E.F. Mckone, B.J. Plant, M. Cohen-Cymberknoh, M. Gur, G. Livnat, M. Mei-Zahav, A. Amato, G. Ferrari, R. Badolato, P. Poli, F. Battistini, V. Donati, E. Bignamini, A. Folino, V. Carnovale, C. Castellani, R. Casciaro, G. Cimino, M. Cipolli, F. Lucca, M. Collura, F. Ficili, V. Daccò, V. Gagliano, G. Pizzamiglio, V. Mencarini, N. Palladino, S. Leonardi, N. Rotolo, M.C. Lucanto, E. Quattromano, V. Lucidi, F. Majo, F. Alghisi, F. Ciciriello, A. Manca, G. Leonetti, M. Maschio, B. Messore, S. Pantano, G. Pisi, C. Spaggiari, V. Raia, C. Laezza, M. Ros, D. Salvatore, G. Taccetti, M. Francalanci, P. Vitullo, A. Zolin, E. Aleksejeva, K. Malakauskas, V. Misevičiene, A. Charatsi, H.D. la Barrière, J. Altenburg, M. Bannier, H. Heijerman, H. Janssens, G. Koppelman, R. van der Meer, P. Merkus, M. Nuijsink, S. Terheggen, H. van der Vaart, G. Wesseling, K. de Winter, I.A. Danevska, T.J. Maretti, S. Fustik, D. Dziecichowicz-Latała, I. Wojsyk-Banaszak, L. Wozniacki, A. Amorim, A.S.A. Santos, S. Castanhinha, F. Gamboa, T.R. Silva, F. Gonçalves, L. Pereira, I. Ciuca, S. Silva, S. Csilla-Enikö, I. Stan, E. Amelina, E. Boitсova, A. Chernyavskaya, Y. Gorinova, S. Krasovskiy, M. Mukhina, V. Sherman, O. Simonova, E. Kondratyeva, E. Bérešová, N. Bližnáková, H. Kayserová, B. Salobir, J. Šelb, U. Krivec, A.J.A. Fernandez, A.A. Fernàndez, F.B. García, M.B. Aparicio, S.C. Corullón, I. Cortell-Aznar, I. Pérez, J.C.I. Colomer, M.C. Roig, I.D. Pecellín, L.D. Cáceres, C.L. Paredes, S. Gartner, J.R.G. Martínez, I.H. Labarga, R.M. Girón-Moreno, E.J. Nogueira, A.L. Ferreiro, A.L. Neyra, E.B. Castro, L.M. Galarraga, C.M. de Vincente, S.M. Navarro, R. Nieto-Royo, C.O. Fuster, M.D. Pastor, E. Pérez-Ruiz, C. Prados-Sánchez, I.R. Cancelo, M.R. de Valbuena, J.R.V. Asensi, V.S. Santiago, P.F. García, R.M. Tawfeeq, A. Banki, M. Gilljam, C. Krantz, U. Lindberg, A. Lindblad, C. Clarenbach, C. Steinack, R. Hage, M. Schuurmans, R. Fischer, R. Kusche, I. Rochat, M. Schuurmans, A. Walter, H. Kamalaporn, S. Hamouda, D.A. Tural, U. Ozcelik, P. Asfuroğlu, T.Ş. Eyüboğlu, A.T. Aslan, A. Bingöl, N. Çobanoğlu, G. Ozcan, D. Dogru, Y. Gökdemir, M. Köse, S. Pekcan, R. Cosgriff
A MULTI-STATE MODEL EVALUATING THE ASSOCIATION OF OXYGEN THERAPY WITH THE COURSE OF CYSTIC FIBROSIS IN EUROPE
2023 S. Gambazza, A. Orenti, A. Zolin, F. Ambrogi
Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry
2023 E. Hatziagorou, S. Fieuws, A. Orenti, L. Naehrlich, U. Krivec, M. Mei-Zahav, A. Jung, K. De Boeck
CHANGES IN FEV1 PERCENT OF PREDICTED OF PEOPLE WITH CYSTIC FIBROSIS IN THE LAST DECADE: USE OF DIFFERENT STATISTICAL METHODS
2023 A. Adamoli, A. Orenti, E. Kerem, E. Hatziagorou, A. Zolin, F. Ambrogi
Evolution of disease in people with cystic fibrosis carrying 2 nonsense mutations in Europe
2023 A. Orenti, A. Zolin, L. Naehrlich, I. Sermet-Gaudelus
A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA
2023 J.D. Bradbury, E. Chesshyre, A. Orenti, A. Jung, A. Warris
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry
2023 S. Gambazza, A. Orenti, G. Pizzamiglio, A. Zolin, C. Colombo, D. Laquintana, F. Ambrogi
10-years changes in lung function of cystic fibrosis patients in Europe: different statistical methods at work
2023 A. Orenti, A. Adamoli, E. Kerem, E. Hatziagorou, A. Zolin, F. Ambrogi
Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children
2023 A. Orenti, I. Pranke, C. Faucon, J. Varilh, A. Hatton, A. Golec, C. Dehillotte, I. Durieu, P. Reix, P. Burgel, D. Grenet, C. Tasset, E. Gachelin, C. Perisson, A. Lepissier, E. Dreano, D. Tondelier, B. Chevalier, L. Weiss, S. Kiefer, M. Laurans, R. Chiron, L. Lemonnier, C. Marguet, A. Jung, A. Edelman, B. Kerem, E. Girodon, M. Taulan-Cadars, A. Hinzpeter, E. Kerem, L. Naehrlich, I. Sermet-Gaudelus
Tight control in patients with rheumatoid arthritis treated with targeted therapies across the COVID-19 pandemic era
2023 A.F. Luppino, G. Cincinelli, A. Orenti, P. Boracchi, E.G. Favalli, R. Caporali, F. Ingegnoli
Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis
2022 E. Kerem, A. Orenti, A. Zolin, L. Annicchiarico, P. Drevinek
Incidence of SARS-CoV-2 and risk factors for severe outcomes in people with cystic fibrosis in Europe
2022 A. Orenti, F. Dunlevy, A. Zolin, J. van Rens, A. Jung, L. Naehrlich
Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation
2022 P. Mondejar-Lopez, A. Zolin, P.W. Garcia-Marcos, M. extordfeminine) Dolores Pastor-Vivero, M. Rosa-Silvestre, F. de Asis Sanchez-Martinez, D. Salvatore, G. Cimino, F. Majo, A. Sole-Jover, O. Asensio de la Cruz, M. Adelaide Calderazzo, G. Pizzamiglio, S. Castillo-Corullon, A. Alvarez-Fernandez, S. Gartner, R. Padoan, V. Carnovale, M. Salvatore, M. extordfeminine) Rosa Moya-Quiles, A. Orenti, G. Glover, M. Sanchez-Solis
Prevalence, trends and outcomes of long-term inhaled antibiotic treatment in people with cystic fibrosis without chronic Pseudomonas aeruginosa infection – A European cystic fibrosis patient registry data analysis
2022 A. Orenti, M. Mei-Zahav, P. Boracchi, A. Lindblad, M. Shteinberg
Disease severity of people with cystic fibrosis carrying residual function mutations: Data from the ECFS Patient Registry
2022 M. Mei Zahav, A. Orenti, A. Jung, E. Hatziagorou, H. Vebert Olesen, E. Kerem
Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy
2021 F. Ingegnoli, G. Cincinelli, A.F. Luppino, E.G. Favalli, A. Orenti, P. Boracchi, R. Caporali
Acute pulmonary embolism in patients presenting pulmonary deterioration after hospitalization for non-critical COVID-19
2021 H. Polo Friz, E. Gelfi, A. Orenti, E. Motto, L. Primitz, T. Donzelli, M. Intotero, P. Scarpazza, G. Vighi, C. Cimminiello, P. Boracchi